Clinical trial

S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps

NCT02291549 · Intersect ENT, Industry · Completed

Key facts

NCT number NCT02291549
Title S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps
Official title A Clinical Evaluation of the Safety and Efficacy of the Steroid-Releasing S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Sinus Obstruction
Acronym RESOLVE_II
Lead sponsor Intersect ENT, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Chronic Sinusitis, Nasal Polyposis
Intervention type Drug, Procedure
Interventions S8 Sinus Implant, Mometasone furoate nasal spray, Sham
Enrollment 300
Start date Dec 1, 2014
Primary completion Oct 1, 2016
Completion Oct 1, 2016
First posted Nov 14, 2014
Last update posted Aug 15, 2018
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies